The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Cell Death and Differentiation

• Publication date

  1998-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.cdd.4400358PMID 10200487
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell Cycle Regulation of the E2F Transcription Factor Involves an Interaction with Cyclin A

  2014cited by this paper
• Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence

  1996cited by this paper
• p21 Disrupts the interaction between cdk2 and the E2F-p130 complex

  1996cited by this paper
• Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint

  1996cited by this paper
• Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis

  1996cited by this paper
• Role for Ceramide in Cell Cycle Arrest (*)

  1995cited by this paper
• Phosphorylation of Raf by ceramide-activated protein kinase

  1995cited by this paper
• E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle.

  1995cited by this paper
• Role of Ceramide in Cellular Senescence (*)

  1995cited by this paper
• Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest.

  1995cited by this paper
• c-Myc and apoptosis.

  1995cited by this paper
• Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members.

  1995cited by this paper
• Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor.

  1994cited by this paper
• The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling.

  1994cited by this paper
• DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control.

  1994cited by this paper
• Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction.

  1994cited by this paper
• D-type cyclins and their cyclin-dependent kinases: G1 phase integrators of the mitogenic response.

  1994cited by this paper
• Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen.

  1994cited by this paper
• The sphingomyelin cycle and the second messenger function of ceramide.

  1994cited by this paper
• Differential regulation of E2F transactivation by cyclin/cdk2 complexes.

  1994cited by this paper
• Stimulation of Human Immunodeficiency Virus Type 1 Expression by Ceramide

  1994cited by this paper
• Binding and suppression of the Myc transcriptional activation domain by p107.

  1994cited by this paper
• DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1

  1994cited by this paper
• The Rb gene suppresses the growth of normal cells.

  1993cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression

  1993cited by this paper
• The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

  1993cited by this paper
• Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor kappa B translocation in intact HL-60 cells.

  1993cited by this paper
• p21 is a universal inhibitor of cyclin kinases

  1993cited by this paper
• The retinoblastoma protein as a transcriptional repressor.

  1993cited by this paper
• Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1 beta.

  1993cited by this paper
• Programmed cell death induced by ceramide.

  1993cited by this paper
• Ceramide activates heterotrimeric protein phosphatase 2A.

  1993cited by this paper
• DNA tumor virus transforming proteins and the cell cycle.

  1993cited by this paper
• Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines.

  1993cited by this paper
• Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein.

  1992cited by this paper
• Sphingolipids and cell function.

  1992cited by this paper
• Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.

  1992cited by this paper
• Identification of a growth suppression domain within the retinoblastoma gene product.

  1992cited by this paper
• Interleukin-1-mediated PGE2 production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide.

  1992cited by this paper
• Cell cycle regulation of the human cdc2 gene.

  1992cited by this paper
• Ceramide stimulates a cytosolic protein phosphatase.

  1992cited by this paper
• myc function and regulation.

  1992influential reference
• Induction of apoptosis in fibroblasts by c-myc protein.

  1992cited by this paper
• E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.

  1992cited by this paper
• Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system.

  1992cited by this paper
• Cyclins and cancer.

  1991cited by this paper
• The E2F transcription factor is a cellular target for the RB protein.

  1991cited by this paper
• Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A.

  1991cited by this paper
• Human DNA polymerase alpha gene: sequences controlling expression in cycling and serum-stimulated cells

  1991cited by this paper
• Ceramide stimulates epidermal growth factor receptor phosphorylation in A431 human epidermoid carcinoma cells. Evidence that ceramide may mediate sphingosine action.

  1991cited by this paper
• Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor alpha.

  1991cited by this paper
• Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation.

  1991cited by this paper
• A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway.

  1990cited by this paper
• Role of ceramide as a lipid mediator of 1 alpha,25-dihydroxyvitamin D3-induced HL-60 cell differentiation.

  1990cited by this paper
• Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo

  1989cited by this paper
• Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter.

  1989cited by this paper
• The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element.

  1989cited by this paper
• Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells

  1982cited by this paper

• Triglyceride lipase PNPLA2–independent suppression of c-MYC signaling by the metabolic coactivator ABHD5 in prostate cancer

  2025cites this paper
• The legacy of a humble scientist: Edoardo Alesse, MD, PhD (1958–2025)

  2025cites this paper
• Ectoine enhances recombinant antibody production in Chinese hamster ovary cells by promoting cell cycle arrest.

  2024cites this paper
• Transcriptome analysis of polyploid giant cancer cells and their progeny reveals a functional role for p21 in polyploidization and depolyploidization

  2024cites this paper
• Tricyclodecan-9-yl-Xanthogenate (D609): Mechanism of Action and Pharmacological Applications

  2022cites this paper
• Transcription factor p53-mediated activation of miR-519d-3p and downregulation of E2F1 attenuates prostate cancer growth and metastasis

  2021cites this paper
• Discovery of novel ceramide analogs with favorable pharmacokinetic properties and combination with AKT inhibitor against colon cancer.

  2021cites this paper
• KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc

  2018cites this paper
• Assessment of cytosolic free calcium changes during ceramide-induced cell death in MDA-MB-231 breast cancer cells expressing the calcium sensor GCaMP6m.

  2018cites this paper
• Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640

  2016influential citation
• Delivery systems of ceramide in targeted cancer therapy: ceramide alone or in combination with other anti-tumor agents

  2016cites this paper
• Suppression of RAD21 Induces Senescence of MDA‐MB‐231 Human Breast Cancer Cells Through RB1 Pathway Activation Via c‐Myc Downregulation

  2016cites this paper
• Sphingosine Kinase Inhibitors as Maintenance Therapy of Glioblastoma After Ceramide-Induced Response.

  2016cites this paper
• Tumor suppressive functions of ceramide: evidence and mechanisms

  2015cites this paper
• Ceramide induced mitophagy and tumor suppression.

  2015cites this paper
• Ceramide and sphingosine-1-phosphate in cancer, two faces of the sphinx

  2015cites this paper
• Ceramide Kinase Contributes to Proliferation but not to Prostaglandin E2 Formation in Renal Mesangial Cells and Fibroblasts

  2014cites this paper
• Ceramide modulates pre-mRNA splicing to restore the expression of wild-type tumor suppressor p53 in deletion-mutant cancer cells.

  2014cites this paper
• The effects of glucose and lipids in steatotic and non‐steatotic livers in conditions of partial hepatectomy under ischaemia‐reperfusion

  2014cites this paper
• Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse.

  2013cites this paper
• Diverse functions of ceramide in cancer cell death and proliferation.

  2013cites this paper
• Ceramide-orchestrated signalling in cancer cells

  2012cites this paper
• Defining a role for sphingosine kinase 1 in p53-dependent tumors

  2011cites this paper
• Regulation of ß-catenin and connexin-43 expression: targets for sphingolipids in colon cancer prevention

  2011cites this paper
• Human Glycolipid Transfer Protein Gene (GLTP) Expression Is Regulated by Sp1 and Sp3

  2010cites this paper
• Alkaline Ceramidase 3 (ACER3) Hydrolyzes Unsaturated Long-chain Ceramides, and Its Down-regulation Inhibits Both Cell Proliferation and Apoptosis*

  2010cites this paper
• Inhibition of p53 sensitizes MCF-7 cells to ceramide treatment.

  2010cites this paper
• Comparative epigenomics of human and mouse mammary tumors

  2009cites this paper
• Regulation of beta-catenin and connexin-43 expression: targets for sphingolipids in colon cancer prevention.

  2009cites this paper
• Retrovirus-mediated Gene Therapy For Farber Disease

  2008cites this paper
• A role for ceramide in driving cancer cell resistance to doxorubicin

  2008cites this paper
• Ceramide-induced G2 arrest in rhabdomyosarcoma (RMS) cells requires p21Cip1/Waf1 induction and is prevented by MDM2 overexpression

  2007cites this paper
• Role for Mammalian Neutral Sphingomyelinase 2 in Confluence-induced Growth Arrest of MCF7 Cells*

  2004cites this paper
• 4-hydroxynonenal and regulation of cell cycle: effects on the pRb/E2F pathway.

  2004cites this paper
• Integration of glycosphingolipid metabolism and cell-fate decisions in cancer and stem cells: Review and Hypothesis

  2004cites this paper
• Ceramide-mediated Macroautophagy Involves Inhibition of Protein Kinase B and Up-regulation of Beclin 1*

  2004cites this paper
• Rituximab antiproliferative effect in B-lymphoma cells is associated with acid-sphingomyelinase activation in raft microdomains.

  2004cites this paper
• Pour obtenir le grade de DOCTEUR DU MUSEUM NATIONAL D'HISTOIRE NATURELLE Discipline : Biologie Moléculaire et Cellulaire

  2003cites this paper
• Ceramide Regulation of Apoptosis versus Differentiation: A Walk on a Fine Line. Lessons from Neurobiology

  2002cites this paper
• Control of the cell cycle by neurotrophins: lessons from the p75 neurotrophin receptor.

  2002cites this paper
• 4-Hydroxynonenal affects pRb/E2F pathway in HL-60 human leukemic cells.

  2002cites this paper
• Regulation of neutral ceramidase in glomerular mesangial cells

  2002cites this paper
• Suppression of c-myc expression and c-Myc function in response to sustained DNA damage in MCF-7 breast tumor cells.

  2001cites this paper
• E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells.

  2001cites this paper
• E 2 F-1 UpRegulates c-Myc and p 14 ARF and Induces Apoptosis in Colon Cancer Cells 1

  2001cites this paper
• Does ceramide play a role in neural cell apoptosis?

  2000cites this paper
• Physiology and pathophysiology of sphingolipid metabolism and signaling.

  2000cites this paper
• Epigenetic aspects of cellular senescence.

  2000cites this paper
• Constitutive activation of NF‐κB and T‐cell leukemia/lymphoma in Notch3 transgenic mice

  2000cites this paper
• Regulation of cyclin-dependent kinase 2 activity by ceramide.

  2000cites this paper
• Expression of Human Papilloma Virus E7 Protein Causes Apoptosis and Inhibits DNA Synthesis in Primary Hepatocytes via Increased Expression of p21Cip-1/WAF1/MDA6 *

  2000cites this paper
• An Ceramide Triggers P53-dependent Apoptosis in Genetically Defined Fibrosarcoma Tumour Cells

  year unknowncites this paper